Why MedAssets (MDAS) Is Spiking Today

NEW YORK (TheStreet) -- MedAssets  (MDAS) was rising 13.82% to $25.12 on Thursday after the company reported its fourth-quarter results and issued guidance for the fiscal year 2014.

The company, which provides clinical resource management and revenue cycle management solutions for the health-care industry, reported earnings per share of 30 cents for the quarter. Revenue increased 4% year over year to $170.5 million thanks to a 7% increase in its clinical resource management segment and a 1% decrease in its revenue cycle management segment. Analysts' consensus estimate called for 28 cents a share on revenue of $165.7 million.

MedAssets forecast revenue growth of 2.9% to 4.9% to a range of $700 million to $714 million. The company also expects earnings per share of $1.33 to $1.43. These figures are in line with the consensus estimate.

Finally, the company's board of directors announced a plan to repurchase $75 million of its own shares during the next 12 months.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

TheStreet Ratings team rates MEDASSETS INC as a "hold" with a ratings score of C. TheStreet Ratings Team has this to say about their recommendation:

"We rate MEDASSETS INC (MDAS) a HOLD. The primary factors that have impacted our rating are mixed - some indicating strength, some showing weaknesses, with little evidence to justify the expectation of either a positive or negative performance for this stock relative to most other stocks. The company's strengths can be seen in multiple areas, such as its growth in earnings per share, increase in net income and revenue growth. However, as a counter to these strengths, we also find weaknesses including generally higher debt management risk, disappointing return on equity and weak operating cash flow."

If you liked this article you might like

New Lifetime High Reached By MedAssets (MDAS)

MedAssets (MDAS) Reaches New Lifetime High Today

MedAssets (MDAS) Stock Gains on Sale to Pamplona Capital Management

Today MedAssets (MDAS) Hits New Lifetime High

Analysts' Actions -- Apple, Disney, Hershey and More